Nguyen Khue V, Sharief Farida S, Chan Sherine S L, Copeland William C, Naviaux Robert K
Department of Medicine, University of California, San Diego School of Medicine, 214 Dickinson Street, Bldg. CTF, Rm. C-103, San Diego, CA 92103-8467, USA.
J Hepatol. 2006 Jul;45(1):108-16. doi: 10.1016/j.jhep.2005.12.026. Epub 2006 Feb 20.
BACKGROUND/AIMS: Alpers syndrome is a developmental mitochondrial DNA depletion syndrome leading to fatal brain and liver disease in children and young adults. Mutations in the gene for the mitochondrial DNA polymerase (POLG) have recently been shown to cause this disorder.
The POLG locus was sequenced in 15 sequential probands diagnosed with Alpers syndrome. In addition, the POLG mutations found to cause Alpers syndrome in the 20 cases published to date were analyzed.
POLG DNA testing accurately diagnosed 87% (13/15=87%: 95% confidence interval=60-98%) of cases. Five new POLG amino acid substitutions (F749S, R852C, T914P, L966R, and L1173fsX) were found that were associated with Alpers syndrome in five unrelated kindreds, and 14 different allelic combinations of POLG mutations were found to cause Alpers syndrome in the 20 probands published to date. The most common Alpers-causing mutation was the A467T substitution, located in the linker region of the pol gamma protein, which accounted for about 40% of the alleles and was present in 65% of the patients. All patients with POLG mutations had either the A467T or the W748S substitution in the linker region.
Screening for A467T and W748S substitutions in POLG now constitutes the most rapid and sensitive test available for confirming the clinical diagnosis of Alpers syndrome.
背景/目的:阿尔珀斯综合征是一种发育性线粒体DNA耗竭综合征,可导致儿童和青年发生致命的脑和肝脏疾病。线粒体DNA聚合酶(POLG)基因的突变最近已被证明可导致这种疾病。
对15例连续诊断为阿尔珀斯综合征的先证者的POLG基因座进行测序。此外,对迄今为止已发表的20例中发现的导致阿尔珀斯综合征的POLG突变进行了分析。
POLG DNA检测准确诊断了87%(13/15 = 87%:95%置信区间 = 60 - 98%)的病例。发现了五个新的POLG氨基酸替代(F749S、R852C、T914P、L966R和L1173fsX),它们与五个无关家系中的阿尔珀斯综合征相关,并且在迄今为止已发表的20例先证者中发现了14种不同的POLG突变等位基因组合可导致阿尔珀斯综合征。最常见的导致阿尔珀斯综合征的突变是A467T替代,位于polγ蛋白的连接区,约占等位基因的40%,存在于65%的患者中。所有携带POLG突变的患者在连接区均有A467T或W748S替代。
筛查POLG中的A467T和W748S替代现在构成了用于确认阿尔珀斯综合征临床诊断的最快速、最灵敏的检测方法。